Acetone Guide: The Domestic Acetone Market Boosted on September 17

Phenol Guide: Yesterday, the domestic Phenol market was weak. Although cost pressures existed, downstream purchasing enthusiasm was not high, lack of confidence in the future market, coupled with the current slow delivery, short sales cycle, business mentality was slightly unstable, TRADERS'inventory sales pressure, eager to go, lack of buying, difficult negotiations, overall weak operation. Future forecast: After all, there is cost support, phenol downward is not easy, or weak shock in the tepid.
2026-08-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
What is acetone structure and formula?
-
Why Are Acetone and Nail Polish Remover Considered the Same A Clear Explanation
-
Acetone market prices rose continuously
-
The 'Discontinuation Tide' Is Here! More than 100 Chemical Companies have Stopped Production!
-
LG Chem Exports Bio-based Phenol and Acetone
-
Why is acetone a good solvent and its uses
-
What is acetone melting point and boiling point
-
What is the other name for acetone
-
Get to Know What Type of Molecule Is AcetoneAnd Its Uses
-
what Are Acetone Uses In Laboratory?
Recommend Reading
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
Brazil Slams Chinese Butyl Acrylate with Anti-Dumping Probe—Trade Tensions Heat Up in Specialty Chemicals
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
Xampla and DIC to Introduce PFAS-Free Morro Coating to Asia
-
India’s Pharma Cost Problem Gets Worse
-
International Oil Prices Experience a "Heart-Stopping Day" as U.S.-Iran Tensions Trigger Massive Shockwaves in the Energy Market
-
The Game Between Supply and Demand Tends Toward Equilibrium; Formic Acid Ranges Sideways
-
Premium Global Chemical Sourcing Requests (15-19 Dec 2025)
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
FDA Warning Letters Put GMP Back in Focus